Efficacy and Safety of AG10 in Subjects With Transthyretin Amyloid Cardiomyopathy
Clinical trial NCT03860935 · COMPLETED
Trial details
- NCT number
- NCT03860935
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-19
- Primary completion
- 2023-05-11
- Enrollment
- 632
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.